Counterfeit retatrutide weight-loss drug leaves Australian patients in acute liver failure
Australian patients who took counterfeit retatrutide-based weight-loss injections sold through unregulated channels have been hospitalised with acute liver failure. The Therapeutic Goods Administration is urging the public to use only approved, prescribed products.
According to ABC News Australia, at least two Australian patients who bought counterfeit retatrutide-labelled weight-loss injections for cash through beauticians were admitted to intensive care with acute liver failure following the second dose. A patient identified as Megan Hancocks shared her experience with the broadcaster.
The Therapeutic Goods Administration (TGA) stressed that retatrutide is not yet approved for any indication in Australia and that there is no quality assurance for products obtained through unregulated channels. The TGA, customs and the federal police are jointly investigating supply sources.
In the international context, shortages of approved GLP-1 analogues are making it easier for counterfeit and compounded products to enter the market. Australian medical associations urged patients to use only prescribed products purchased through pharmacies.
Read next
Where Iran's political factions stand on the US peace deal as implementation begins
Iran's rival political factions are visibly divided over how to implement the memorandum of understanding signed with the United States. Reformists view the deal as an opportunity to ease sanctions, while the conservative camp demands that "red lines" be respected. The stance of the Revolutionary Guards is seen as the key factor shaping the next steps.
Médecins Sans Frontières warns conditions in Lebanon's Nabatieh resemble a 'death trap'
Experts warn H5N1 bird flu could be catastrophic for Australia's vulnerable native species
Telegram challenges India ban imposed over exam paper leak concerns
Beijing to expand maritime surveys east of Taiwan to assert sovereignty claim
